JUNO THERAPEUTICS

juno-therapeutics-logo

Juno is a clinical-stage company that brings together three of the world’s leading cancer centers – Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and Seattle Children’s Research Institute – in unique partnership to advance a broad pipeline of breakthrough immunotherapies. With one of the largest ever Series A investments for a biotech startup, Juno will build on the foundation of novel immunotherapies to develop two distinct and complementary platforms – CARs and TCRs.
#People #Financial #Event #Website #More

JUNO THERAPEUTICS

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Clinical Trials Health Care Medical Therapeutics

Founded:
2013-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.junotherapeutics.com

Total Employee:
251+

Status:
Active

Contact:
+1 206-696-0703

Email Addresses:
[email protected]

Total Funding:
310 M USD

Technology used in webpage:
SPF Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS DoubleClick.Net Amazon Virginia Region Amazon Route 53



Current Advisors List

jose-baselga_image

Jose Baselga Scientific Advisor @ Juno Therapeutics
Advisor

marc-lavigne_image

Marc Lavigne Member of the Board of Directors @ Juno Therapeutics
Board_member

howard-pien_image

Howard Pien Board of Directors @ Juno Therapeutics
Board_member

lawrence-corey_image

Lawrence Corey Scientific Advisor @ Juno Therapeutics
Advisor

richard-klausner_image

Richard Klausner Member of the Board of Directors @ Juno Therapeutics
Board_member

hans-bishop_image

Hans Bishop Board of Directors @ Juno Therapeutics
Board_member

hal-barron_image

Hal Barron Member of the Board of Directors @ Juno Therapeutics
Board_member

anthony-evnin_image

Anthony Evnin Board of Directors @ Juno Therapeutics
Board_member

Current Employees Featured

lawrence-corey_image

Lawrence Corey
Lawrence Corey Co-Founder @ Juno Therapeutics
Co-Founder

hans-bishop_image

Hans Bishop
Hans Bishop Co-Founder & CEO @ Juno Therapeutics
Co-Founder & CEO
2013-10-01

cynthia-elkins_image

Cynthia Elkins
Cynthia Elkins EVP & CIO @ Juno Therapeutics
EVP & CIO
2017-12-01

hyam-levitsky_image

Hyam Levitsky
Hyam Levitsky Executive Vice President Research, Chief Scientific Officer @ Juno Therapeutics
Executive Vice President Research, Chief Scientific Officer
2015-05-01

isabelle-rivière_image

Isabelle Rivière
Isabelle Rivière Scientific & Co-Founder @ Juno Therapeutics
Scientific & Co-Founder

michel-sadelain_image

Michel Sadelain
Michel Sadelain Scientific Co-Founder @ Juno Therapeutics
Scientific Co-Founder

steve-shamah_image

Steve Shamah
Steve Shamah Head Of Scientific Operation @ Juno Therapeutics
Head Of Scientific Operation
2016-02-01

bill-donahue_image

Bill Donahue
Bill Donahue Senior Director, Head of Sequencing @ Juno Therapeutics
Senior Director, Head of Sequencing

stan-riddell_image

Stan Riddell
Stan Riddell Scientific Co-Founder @ Juno Therapeutics
Scientific Co-Founder

Founder


hans-bishop_image

Hans Bishop

isabelle-rivière_image

Isabelle Rivière

michael-jensen_image

Michael Jensen

michel-sadelain_image

Michel Sadelain

phil-greenberg_image

Phil Greenberg

renier-brentjens_image

Renier Brentjens

stan-riddell_image

Stan Riddell

Stock Details


Company's stock symbol is NASDAQ:JUNO

Acquisitions List

Date Company Article Price
2016-07-14 RedoxTherapies RedoxTherapies acquired by Juno Therapeutics N/A
2016-06-22 Contura Contura acquired by Juno Therapeutics N/A
2016-01-11 AbVitro AbVitro acquired by Juno Therapeutics 125 M USD
2015-06-02 X BODY X BODY acquired by Juno Therapeutics 44 M USD
2015-05-12 Stage Cell Therapeutics Stage Cell Therapeutics acquired by Juno Therapeutics 22 M USD

Investors List

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series B - Juno Therapeutics

bezos-expeditions_image

Bezos Expeditions

Bezos Expeditions investment in Series B - Juno Therapeutics

venrock_image

Venrock

Venrock investment in Series B - Juno Therapeutics

alaska-permanent-fund_image

Alaska Permanent Fund

Alaska Permanent Fund investment in Series B - Juno Therapeutics

venrock_image

Venrock

Venrock investment in Series A - Juno Therapeutics

bezos-expeditions_image

Bezos Expeditions

Bezos Expeditions investment in Series A - Juno Therapeutics

alaska-permanent-fund_image

Alaska Permanent Fund

Alaska Permanent Fund investment in Series A - Juno Therapeutics

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series A - Juno Therapeutics

Investments List

Date Company Article Money raised
2020-06-11 JW Therapeutics Juno Therapeutics investment in Series B - JW Therapeutics 100 M USD
2018-03-07 JW Therapeutics Juno Therapeutics investment in Series A - JW Therapeutics 90 M USD
2015-05-27 Editas Medicine Juno Therapeutics investment in Funding Round - Editas Medicine 47 M USD

Newest Events participated

clinical-operations-strategy-meeting-west-coast-2018_event_image Participated in Clinical Operations Strategy Meeting West Coast 2018 on 2018-05-15 as speaker

oncology-strategy-meeting-us-west-coast-2018_event_image Participated in Oncology Strategy Meeting US West Coast 2018 on 2018-05-14 as speaker

Official Site Inspections

http://www.junotherapeutics.com

  • Host name: ec2-52-23-148-80.compute-1.amazonaws.com
  • IP address: 52.23.148.80
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Juno Therapeutics" on Search Engine